Dose-Effect Relationship of Chitosan and Danshen Combined Injection for Fallopian Tube Recanalization
- PMID: 35774613
- PMCID: PMC9237208
- DOI: 10.3389/fphar.2022.935117
Dose-Effect Relationship of Chitosan and Danshen Combined Injection for Fallopian Tube Recanalization
Abstract
Objectives: This study examined the dose-effect relationship of chitosan and danshen combined injections on the long-term prevention of fallopian tube re-obstructions, with increased pregnancy rates in infertile women. Methods: High-performance liquid chromatography was used to determine the content changes of combined chitosan and danshen injection. Two hundred and eighty patients with fallopian tube obstructions were randomly assigned to four groups. Group A (control group, saline), Group B (2 ml chitosan, 4 ml danshen), Group C (2 ml chitosan, 10 ml danshen), and Group D (1 ml chitosan, 10 ml danshen). Injections were administered after tubal recanalization. Results: The effective constituent of chitosan and danshen injection was stable. Tubal patency rate was 94.2% and 87.3% in Group C after 1 and 3 years, respectively, which was significantly higher than Groups A (38.6%, 31.5%), B (73.5%, 64.1%), and D (68.5%, 50.7%). Intrauterine pregnancy rates were 61.8% and 79.4% in Group C after 1 and 3 years, respectively, and were significantly higher than Groups A (31.8%, 34.8%), B (40.1%, 62.5%), and D (38.5%, 58.5%) (p < 0.05). Conclusion: Combined Chitosan and danshen injections prevented tubal obstruction and increased pregnancy rates for long periods using an optimal ratio of 1 part chitosan and 5 parts danshen.
Keywords: chitosan; danshen; dose-effect relationships; drug delivery; fallopian tube recanalization.
Copyright © 2022 Huang, Wu, Liang, Wang, He, Xie, Lu, Su and Tang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Combined chitosan and Dan-shen injection for long-term tubal patency in fallopian tube recanalization for infertility.Drug Deliv Transl Res. 2019 Aug;9(4):738-747. doi: 10.1007/s13346-018-00611-0. Drug Deliv Transl Res. 2019. PMID: 30610502 Free PMC article. Clinical Trial.
-
[Comparative study on different anti-adhesion agents in preventing tubal obstruction after interventional recanalization.].Zhonghua Fu Chan Ke Za Zhi. 2009 Nov;44(11):821-4. Zhonghua Fu Chan Ke Za Zhi. 2009. PMID: 20079032 Chinese.
-
[Analysis of 1006 cases with selective salpingography and fallopian tube recanalization].Zhonghua Fu Chan Ke Za Zhi. 2004 Feb;39(2):80-2. Zhonghua Fu Chan Ke Za Zhi. 2004. PMID: 15059580 Clinical Trial. Chinese.
-
Fallopian tube recanalization: lessons learnt and future challenges.Womens Health (Lond). 2010 Jul;6(4):531-48, quiz 548-9. doi: 10.2217/whe.10.34. Womens Health (Lond). 2010. PMID: 20597618 Review.
-
A review of selective salpingography and fallopian tube catheterization.Radiographics. 2000 Nov-Dec;20(6):1759-68. doi: 10.1148/radiographics.20.6.g00nv211759. Radiographics. 2000. PMID: 11112827 Review.
Cited by
-
Quercetin of huoxuehuayu tongluo decoction and azithromycin combination therapy effectively improves rat tubal factor infertility by inhibiting inflammation.Iran J Basic Med Sci. 2024;27(6):685-694. doi: 10.22038/IJBMS.2024.72049.15662. Iran J Basic Med Sci. 2024. PMID: 38645489 Free PMC article.
References
LinkOut - more resources
Full Text Sources